DELFI Diagnostics

DELFI Diagnostics is a biotechnology company based in Maryland, focused on early cancer detection through advanced genomic analysis and machine learning. The company specializes in next-generation liquid biopsy technologies that identify cancer-associated DNA fragmentation patterns in blood samples. With a team of 51-200 employees, DELFI aims to make cancer screening accessible and effective, particularly for high-risk populations. The company's core technology includes a fragmentomics platform that analyzes millions of DNA fragments using whole genome sequencing and machine learning. This allows for high-sensitivity detection of multiple cancer types through blood-based tests, which are designed to be integrated into routine clinical practice. DELFI's early detection tests target asymptomatic cancer, enhancing screening options for individuals who may face barriers to traditional methods. DELFI has established strategic partnerships, including collaborations with the Merck Global Health Innovation Fund and Incendia Therapeutics, to support its growth and commercialization efforts. The company is committed to advancing cancer detection methodologies and has been recognized for its innovative approach in recent industry presentations.

Research Baltimore, United States ~114 employees

Work at DELFI Diagnostics in HR or recruiting? Claim this page

Employees
114
+2.7% in the 3 months to Sep 2026
Revenue / employee
$66.7K
Revenue ~$7.6M
Total funding
$331M
Last round Jun 2024
12-month attrition
28.8%
Tech: 18.2%
H1B filings, FY2026
2
Sponsors visas
Open jobs
2
Last 30 days

Headcount trend

DELFI Diagnostics went from 142 employees in Oct 2024 to 114 in Sep 2026. Apr to Sep 2026: 5 people joined, 4 left.

Funding rounds

Total funding$331M
Funding rounds5
Investors20

Org structure

Headcount by department

Other50
Engineering36
Operations12
Finance7
Product3
Success3
HR2
Marketing1

H-1B sponsorship

H-1B Sponsorship Limited
H-1B Filings by Department
Engineering3
Operations1
Finance1

The department split adds up all the years listed above. FY2026 alone: 2 filings.

Peer reviews

Worked with someone at DELFI Diagnostics?

Anonymous peer reviews on OffTheRecord

Read or write a review

Similar companies

Hiring now

DELFI Diagnostics FAQ

How many employees does DELFI Diagnostics have?

DELFI Diagnostics has about 114 employees, up 2.7% over the 3 months to Sep 2026.

Does DELFI Diagnostics sponsor H1B visas?

Yes. DELFI Diagnostics filed 2 H1B (LCA) applications in FY2026, according to the latest U.S. Department of Labor disclosures. Most of them were for Engineering roles.

What is DELFI Diagnostics's revenue per employee?

DELFI Diagnostics makes about $67K in revenue per employee, based on $7.6M annual revenue and 114 employees.

How much funding has DELFI Diagnostics raised?

DELFI Diagnostics has raised $330.52M in total funding.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.